Malignant Neoplasm of Unknown Primary Site B052
Current RMA Instruments
| Reasonable Hypothesis | 103 of 2022 |
| Balance of Probabilities | 104 of 2022 |
Malignant Neoplasm of the Nasopharynx B022
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP&nb |
Malignant Neoplasm of the Thyroid Gland B043
Current RMA Instruments
39 of 2022 | |
40 of 2022 |
Malignant Melanoma of the Skin B026
Current RMA Instruments:
| Reasonable Hypothesis SOP | 102 of 2015 |
| Balance of Probabilities SOP | 103 of 2015 |
Changes from Previous Instruments:
Malignant Neoplasm of the Prostate B018
Current RMA Instruments
| Reasonable Hypothesis | 3 of 2023 |
Malignant Neoplasm of the Ovary B023
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2018 |
| Balance of Probabilities SOP | 10 of 2018 |
Changes from previous Instruments
Primary Myelofibrosis B068
Current RMA Instruments
| Reasonable Hypothesis SOP | 89 of 2021 |
| Balance of Probabilities SOP | 90 of 2021 |
Changes from previous Instruments
Polycythaemia Vera D001
Current RMA Instruments
| Reasonable Hypothesis SOP | 87 of 2021 |
| Balance of Probabilities SOP | 88 of 2021 |
Changes from previous Instruments
Malignant Neoplasm of the Oesophagus B033
Current RMA Instruments:
| Consolidated RH SOP | 120 of 2015 as amended by 21 of 2017 |
| Balance of Probabilities SOP | 121 of 2015 |
Changes from previous Instruments:
Soft Tissue Sarcoma B009
Current RMA Instruments
| Reasonable Hypothesis SOP | 76 of 2023 as amended |
| Balance of Probabilities SOP | 77 of 2023 as amended |